NCT05119465 COVID-19 Clinical Status Associated With Outcome Severity: An Unsupervised Machine Learning Approach Status COMPLETED Phase N/A
NCT05115019 A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19) Status WITHDRAWN Phase PHASE2/PHASE3
NCT05113862 A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 Status COMPLETED Phase PHASE1
NCT05113849 Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) Status UNKNOWN Phase PHASE1
NCT05112913 Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05112900 Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts) Status COMPLETED Phase PHASE3
NCT05109598 Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell) Status COMPLETED Phase PHASE2
NCT05107557 Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) Status COMPLETED Phase PHASE4
NCT05107271 Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease Status COMPLETED Phase N/A
NCT05107245 Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19. Status COMPLETED Phase N/A
NCT05105295 Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected Status UNKNOWN Phase PHASE4
NCT05104840 A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus Status TERMINATED Phase N/A